Homepage Services Sectors and Markets

Life Sciences & Healthcare

Rapid transformation in the Life Sciences & Healthcare industry requires organisations to strike a balance between market potential, policy compliance and patient demands with continued innovation.

We are all affected by this sector and it falls under heavy social and political scrutiny. Regulation of competition in the sector has also made it increasingly dynamic and challenging. As the demand for life sciences and healthcare services is ever-growing, so too are the strains and scrutiny placed on its decision makers.

With the largest Life Sciences & Healthcare Team in de Dutch market, we can relate to our clients and deliver top tier services to our clients during all the stages of business lifecycle.

Good ‘climate’

Recent changes in the Dutch healthcare system have allowed investors and care providers to operate from the Netherlands when deploying innovative care concepts. The relocation of the EMA to Amsterdam attracts also new pharmaceutical companies and generates a lot of activity.

Remodelling of the healthcare system has resulted in hospital mergers, partnerships, and reorganisation of healthcare. Besides that, E-Health plays an increased role in prevention and screening. This growth in innovation is evident across other Loyens & Loeff markets in Belgium, Switzerland and Luxembourg.

Product development in the pharma industry

Successfully developing and marketing products in the pharmaceutical and life sciences sectors requires first-rate legal and tax support. This support must include an expert understanding of clinical research, intellectual property, tax planning, regulatory compliance, and pricing issues.

02-01-2023

Capital markets outlook 2023

Our 2023 capital markets outlook is available. In this outlook we highlight 10 key developments which should be on the radar of parties active in the capital markets of our home markets (the Netherlands, Belgium, Luxembourg and Switzerland) and provi

We are leaders and experts in the Life Sciences & Healthcare industry. Our team works collaboratively with clients ranging from biotech and start-up backgrounds, all the way to global pharmaceutical leaders. In recent years, our team of specialists have also assisted nursing healthcare insurers, medical aid suppliers, medical specialist companies (MSCs), healthcare business owners, investors institutions and academic hospitals.

What can you expect from us:

Pragmatic, clear, concise, and well thought out advice
Responsive service with short delivery time frames
Knowledge of the tax aspects involved in legal issue;
In-depth knowledge of the sector and future developments
Creative answers and solutions
First-rate service - with fixed contacts we are often able to assist within a day
Competitive fees based on our extensive track record and specialisation

Life Sciences:

Our team offers you a wide range of services in the Life Sciences industry:

Regulatory matters e.g., marketing authorisation, DMFs, GMP compliance, and manufacturing licenses
Pricing & reimbursement
Privacy and data protection
Drafting and negotiating agreements
Advertising, marketing, and product liability e.g., litigation and insurance
Competition and anti-trust
Corporate and tax structuring (also M&A)
Transfer pricing, customs, and VAT

Healthcare:

Our expertise and projects in the Healthcare industry include:

Representing investors and care providers in respect of mergers and acquisitions
Competition law and governance in partnerships across the healthcare sector
Acting for healthcare insurers and care providers on audits, purchasing disputes and insolvencies
Acting as a ‘boardroom’ advisor to healthcare institutions on governance issues
Healthcare real estate

The processing and transferring of personal data in a secure and lawful manner, has become extremely important and challenging for businesses globally.

23-12-2022

Croma-Pharma GmbH signed a Business Combination Agreement with European Healthcare Acquisition & Growth Company B.V.

European Healthcare Acquisition & Growth Company B.V. (“EHC”), a Dutch operators-led special purpose acquisition company, and Austrian-based Croma-Pharma GmbH (”Croma”).

COVID-19

The implications of the COVID-19 pandemic reach across borders, industries, and legal disciplines. That is why Loyens & Loeff has set up dedicated expert teams - to offer you an integrated answer to all your legal and tax questions related to the cor

15-10-2021

Op 12 maart 2020 werd door het kabinet aangekondigd dat vanwege COVID-19 iedereen die daartoe in staat was de komende twee weken thuis moest werken.

Digital Economy

Digital transformation is all about using the latest technology to improve your business model. Digital technology creates new business opportunities which in turn creates a whole new range of tax and legal challenges such as contracting, data protec

20-03-2023

SMSG published its advice on potential practical challenges that may arise in the implementation of the Digital Operational Resilience Act.

We are happy to keep you up to date about all the latest Life Sciences & Healthcare news and legal developments. We therefore invite you to read our brochures, newsletters and newsflashes and keep an eye out for our future events

Follow the Loyens & Loeff Life Sciences page on LinkedIn and keep informed of the latest topics.

Follow the Loyens & Loeff Life Healthcare page on LinkedIn and keep informed of the latest topics.

What others say

Clients laud the team for being "customer-oriented, easily accessible, with up-to-date knowledge."

Chambers & Partners Europe 2021

Another client praises the firm's ability "to support and advise in a very clear and practical way and not being shy in taking the lead."

Chambers & Partners Europe 2021

Clients laud the team for being "customer-oriented, easily accessible, with up-to-date knowledge."

Chambers & Partners Europe 2021

Another client praises the firm's ability "to support and advise in a very clear and practical way and not being shy in taking the lead."

Chambers & Partners Europe 2021

"I really enjoy working with the healthcare team of Loyens & Loeff."

Legal 500 (2022)

"The team has a very high level of knowledge."

Legal 500 (2022)

"They take the time to get to know the customer and to identify their needs."

Legal 500 (2022)

"It was a real pleasure to work with this team in difficult times."

Legal 500 (2022)

"The team is very knowledgeable, responsive, and just as important, pleasant to work with."

Legal 500 (2022)

"They take their clients seriously and listen to feedback."

Legal 500 (2022)

"Pleasant and knowledgeable employees."

Legal 500 (2022)

"L&L delivers practical and useful responses and in a timely manner. I enjoy working with them when I have food related cases."

Legal 500 (2022)

"For a tech firm like ours it is important that our lawyers understand our business. L&L knows the food industry well but also has tech-knowledge and insights. Their digital economy team connects with their food team for businesses like ours, where the food and tech sometimes comes together."

Legal 500 (2022)

"I appreciate their proactive and tailored news dissemination. Usually law firms send out general newsflashes etc., but the intel we receive from L&L is custom gathered and therefore always relevant."

Legal 500 (2022)

"It’s an outstanding, smart team and also fun to work with. They have a strong track record in technology contracting and are very experienced in tech M&A deals. The team is always aware of the newest technologies."

Legal 500 (2022)

"High level of service."

Chambers & Partners Europe (2022)

"Knowledge of the sector and the issues involved."

Chambers & Partners Europe (2022)

Insights

Topics

News & Events

Featured

Services

Sectors & Markets

Expertises

Featured